Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Genfleet Therapeutics Announced Clinical Trial Collaboration And Supply Agreement With BeiGene Switzerland To Start A Combination Study Of GFH009 And Brukinsa (Zanubrutinib) In Phase 1B/2 Trial For Diffuse Large B Cell Lymphoma

Author: Benzinga Newsdesk | March 28, 2024 07:14am

Posted In: BGNE